Autobio Diagnostics Co., Ltd. (SHA:603658)
China · Delayed Price · Currency is CNY 29.86
-1.04 (-3.37%)
Jun 24, 2026, 3:00 PM CST
Autobio Diagnostics Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Autobio Diagnostics stock has a consensus rating of "Buy" and an average price target of ¥39.42. The average 1-year stock price forecast is 32.02% higher than the current stock price, while the lowest is ¥31.00 (+3.82%) and the highest is ¥44.20 (+48.02%).
Price Target: ¥39.42 (+32.02%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Autobio Diagnostics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 5 | 4 | 4 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 7 | 6 | 6 | 7 | 6 |
Financial Forecast
Revenue This Year
4.53B
from 4.23B
Increased by 7.18%
Revenue Next Year
5.04B
from 4.53B
Increased by 11.33%
EPS This Year
2.45
EPS Next Year
2.81
from 2.45
Increased by 14.69%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.6B | ||
| Avg | 4.5B | ||
| Low | 4.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 9.6% | ||
| Avg | 7.2% | ||
| Low | 1.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.45 | ||
| Avg | 2.45 | ||
| Low | 2.45 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 28.9% | ||
| Avg | 28.9% | ||
| Low | 28.9% |